With one click, developers can implement a Jira issue, whether a story, bug, task, or subtask, and the implementation will generate code from requirements in that issue, Tabnine said. Afterward, ...

As tools like Claude Code get better, more and more developers are happy to hand off coding tasks to them. The way software gets built has changed for good. The vibes were strong at Code with Claude, ...

Artificial intelligence tools are making it faster than ever to reproduce creative work. Does copyright even matter anymore? By Meaghan Tobin Reporting from Taipei, Taiwan Sigrid Jin was waiting to ...

Nathan Round, part of GameRant's talented Game Guides Team, is the leading voice for Call of Duty guides. From meta loadouts to the best weapons for each season, he takes pride in crafting top-notch ...

From shimmering and embossed covers to boatloads of bonus features, it’s hard to beat the prestige of owning a physical Blu-ray copy of your favorite films – and that’s before considering the image ...

Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...

Multiply, touted as the first artificial intelligence (AI)-native media agency for B2B companies, has emerged from stealth with $9.5 million in funding to introduce what it calls the next paradigm: ...

The MarketWatch News Department was not involved in the creation of this content. San Francisco, CA, March 18, 2026 (GLOBE NEWSWIRE) -- Multiply is the first AI-native media agency for B2B companies.

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

NO BS! Let's break it down into simple terms. Above are the reasons why RLM is not just a tool calling with python in a Loop. REPL is a short form for Read Eval Print Loop. It is a simple environment ...

Generate:Biomedicines' anti-TSLP antibody GB-0895 is currently being evaluated in a pair of phase 3 studies for severe asthma. (Stock photo/Getty Images) Clinical-stage antibody company ...